Home / Inspections / 1025781

FDA Inspection 1025781 — The Nebraska Medical Center

The Nebraska Medical Center — FEI 3000210077

The FDA completed an inspection of The Nebraska Medical Center on August 24, 2017 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Omaha, NE (United States)

Facility

Other inspections at this facility

  • 1202909 (NAI Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1077742 (NAI Thu Dec 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935814 (NAI Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 803217 (NAI Fri Oct 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 727158 (NAI Fri May 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources